CenterStar Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

CenterStar Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-30,300	Closed	-$1.84M	–	278
2026 Q1	$1.84M	Sell	30,300 -28,000	-48%	-$1.63M	0.23%	88
2025 Q4	$3.14M	Buy	+58,300	New	+$2.8M	0.88%	20
2025 Q2	–	Sell	-54,800	Closed	-$3.34M	–	235
2025 Q1	$3.34M	Buy	54,800 +5,500	+11%	+$321K	0.8%	30
2024 Q4	$2.79M	Buy	+49,300	New	+$2.75M	0.97%	21
2022 Q2	–	Hold	0	–	-$4.85M	–	422
2022 Q1	–	Hold	0	–	–	–	42
2021 Q2	–	Hold	0	–	-$2.71M	–	504
2021 Q1	–	Hold	0	–	–	–	89
2020 Q4	–	Hold	0	–	–	–	150
2020 Q2	–	Hold	0	–	-$115K	–	733
2020 Q1	–	Hold	0	–	–	–	288
2019 Q4	–	Hold	0	–	-$45K	–	491
2019 Q3	–	Hold	0	–	–	–	186
2019 Q1	–	Hold	0	–	-$546K	–	400
2018 Q4	–	Hold	0	–	–	–	30
2018 Q3	–	Hold	0	–	–	–	136

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

CenterStar Asset Management's BMY Position: Q2 2026 in Review

CenterStar Asset Management sold out of Bristol-Myers Squibb (BMY) in Q2 2026, closing a stake of 5,284 shares — an estimated $320K sold.

CenterStar Asset Management first reported a position in BMY in Q2 2023 and held it in 3 quarters. The position peaked at $640K in Q4 2024. 2,521 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

CenterStar Asset Management reported no remaining Bristol-Myers Squibb position as of Q2 2026 after selling out during the quarter.
CenterStar Asset Management sold 5,284 Bristol-Myers Squibb shares in Q2 2026, an estimated $320K.
CenterStar Asset Management first reported a position in Bristol-Myers Squibb in Q2 2023 and held it in 3 quarters.
CenterStar Asset Management's Bristol-Myers Squibb position peaked at $640K in Q4 2024.
2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on CenterStar Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.